We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
-2.65%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$3.16B
AUM Growth
-$738M
Cap. Flow
-$649M
Cap. Flow %
-20.54%
Top 10 Hldgs %
17.54%
Holding
750
New
208
Increased
146
Reduced
154
Closed
235

Sector Composition

Rank Sector Weight
1 Real Estate 13.02%
2 Consumer Discretionary 8.61%
3 Industrials 6.83%
4 Technology 6.65%
5 Utilities 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHC icon
476
Acadia Healthcare
ACHC
$3.01B
$392K 0.01%
10,000
-25,000
-71% -$917K
VRAY
477
DELISTED
ViewRay, Inc.
VRAY
$386K 0.01%
+60,000
New +$500K
CVA
478
DELISTED
Covanta Holding Corporation
CVA
$363K 0.01%
+25,000
New +$394K
RDUS
479
CALL
DELISTED
Radius Health, Inc.
RDUS
$359K 0.01%
+10,000
New +$361K
ALDX icon
480
Aldeyra Therapeutics
ALDX
$95.3M
$356K 0.01%
47,400
-2,600
-5% -$19.7K
TELL
481
DELISTED
Tellurian Inc.
TELL
$350K 0.01%
48,483
-1,517
-3% -$14.6K
HSIC icon
482
Henry Schein
HSIC
$9.76B
$336K 0.01%
+6,375
New +$353K
BX icon
483
Blackstone
BX
$107B
$320K 0.01%
10,000
-55,000
-85% -$1.88M
PTLA
484
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$317K 0.01%
9,700
-300
-3% -$13.2K
AKAO
485
DELISTED
Achaogen Inc
AKAO
$313K 0.01%
24,180
-10,820
-31% -$123K
BEL
486
DELISTED
Belmond Ltd.
BEL
$312K 0.01%
+28,000
New +$344K
ATRC icon
487
AtriCure
ATRC
$2.02B
$308K 0.01%
15,000
-5,000
-25% -$90.3K
APO icon
488
Apollo Global Management
APO
$71.9B
$296K 0.01%
+10,000
New +$336K
NSTG
489
DELISTED
NanoString Technologies, Inc.
NSTG
$282K 0.01%
37,500
+2,500
+7% +$18.1K
MGM icon
490
MGM Resorts International
MGM
$11.8B
$280K 0.01%
8,000
-66,000
-89% -$2.32M
OBSV
491
DELISTED
ObsEva SA Ordinary Shares
OBSV
$270K 0.01%
+20,000
New +$245K
EPZM
492
DELISTED
Epizyme, Inc
EPZM
$266K 0.01%
+15,000
New +$253K
IMDZ
493
DELISTED
Immune Design Corp.
IMDZ
$264K 0.01%
80,000
-89,034
-53% -$315K
RARE icon
494
Ultragenyx Pharmaceutical
RARE
$2.56B
$255K 0.01%
+5,000
New +$252K
KERX
495
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$254K 0.01%
62,000
-2,000
-3% -$9.31K
CYTK icon
496
Cytokinetics
CYTK
$10.8B
$252K 0.01%
35,000
-5,000
-13% -$42.9K
AGEN
497
Agenus
AGEN
$275M
$236K 0.01%
2,548
-2,037
-44% -$181K
LOXO
498
DELISTED
Loxo Oncology, Inc
LOXO
$231K 0.01%
2,000
-17,000
-89% -$1.81M
INSY
499
DELISTED
Insys Therapeutics, Inc.
INSY
$222K 0.01%
36,700
+2,200
+6% +$18.2K
MDY icon
500
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$217K 0.01%
+634
New +$221K

Similar funds

Weiss Multi-Strategy Advisers's Q1 2018 Portfolio in Review

As of Q1 2018, Weiss Multi-Strategy Advisers held 750 positions worth $3.16B, down 19% from $3.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $649M in Q1 2018, closing 235 positions and reducing 154 holdings. Its most notable exit was Johnson & Johnson, an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 13% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in VICI Properties worth $48.9M.

  • Weiss Multi-Strategy Advisers's largest Q1 2018 buy was VICI Properties: 2,668,289 shares worth $48.9M.
  • Weiss Multi-Strategy Advisers added most to Canadian National Railway in Q1 2018, an estimated $29.6M increase.
  • Weiss Multi-Strategy Advisers's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $597M.
  • Weiss Multi-Strategy Advisers fully exited Johnson & Johnson in Q1 2018, selling an estimated $30.3M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 18% of its $3.16B portfolio in Q1 2018.
  • Weiss Multi-Strategy Advisers opened 208 new positions and closed 235 in Q1 2018.
  • Weiss Multi-Strategy Advisers's portfolio value fell 19% quarter-over-quarter to $3.16B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2018, filed 15 May 2018.